semaglutide thyroid cancer risk Ozempic and debate Semaglutide (Ozempic), Tirzeparide(Mounjaro) Can Cause
Description
Moro, T., Tinsley, G., Bianco, A., Marcolin, G., Pacelli, Q
Semaglutide is an FDA-approved GLP-1 receptor agonist designed for chronic weight management in adults with obesity, or those overweight with at least one weight-related condition
A few worry it might interfere with the medication itself
Making an effort to reduce stress
Common Side Effects Nausea : Your stomach might feel queasy, especially when you first start
